71.23
price down icon1.06%   -0.76
after-market アフターアワーズ: 71.23
loading
前日終値:
$71.99
開ける:
$71.35
24時間の取引高:
219.22K
Relative Volume:
0.65
時価総額:
$1.64B
収益:
$923.71M
当期純損益:
$84.68M
株価収益率:
18.07
EPS:
3.9419
ネットキャッシュフロー:
$182.81M
1週間 パフォーマンス:
-2.20%
1か月 パフォーマンス:
-10.06%
6か月 パフォーマンス:
-6.93%
1年 パフォーマンス:
-25.80%
1日の値動き範囲:
Value
$71.11
$72.06
1週間の範囲:
Value
$71.11
$74.99
52週間の値動き範囲:
Value
$70.15
$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
名前
Ani Pharmaceuticals Inc
Name
セクター
Healthcare (1074)
Name
電話
(609) 759-1810
Name
住所
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, MN
Name
職員
970
Name
Twitter
Name
次回の収益日
2026-08-07
Name
最新のSEC提出書
Name
ANIP's Discussions on Twitter

Compare ANIP vs TAK, TEVA, HLN, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANIP icon
ANIP
Ani Pharmaceuticals Inc
71.23 1.78B 923.71M 84.68M 182.81M 3.9419
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.45 57.90B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
36.36 42.89B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.60 43.41B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
75.81 31.00B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
487.61 22.35B 3.17B 1.29B 1.01B 27.09

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 開始されました H.C. Wainwright Buy
2025-03-14 開始されました Jefferies Buy
2025-03-12 開始されました JP Morgan Overweight
2024-12-11 開始されました Leerink Partners Outperform
2024-10-11 開始されました Piper Sandler Overweight
2024-03-15 開始されました CapitalOne Overweight
2023-08-22 繰り返されました H.C. Wainwright Buy
2023-03-01 開始されました Guggenheim Buy
2022-09-07 開始されました H.C. Wainwright Buy
2021-11-02 開始されました Truist Buy
2020-05-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-09-12 開始されました Guggenheim Buy
2019-05-10 ダウングレード Raymond James Strong Buy → Outperform
2017-10-16 繰り返されました Canaccord Genuity Buy
2017-07-31 開始されました Canaccord Genuity Buy
2017-02-22 ダウングレード ROTH Capital Buy → Neutral
2016-06-23 開始されました Raymond James Strong Buy
2016-05-24 ダウングレード Standpoint Research Buy → Hold
2015-11-13 開始されました Standpoint Research Buy
2015-09-28 アップグレード ROTH Capital Neutral → Buy
2015-08-05 繰り返されました Oppenheimer Outperform
2015-08-04 繰り返されました ROTH Capital Neutral
2015-07-31 繰り返されました Oppenheimer Outperform
2015-07-15 繰り返されました ROTH Capital Neutral
2015-06-23 繰り返されました Oppenheimer Outperform
2015-05-18 繰り返されました ROTH Capital Neutral
2015-05-06 繰り返されました Oppenheimer Outperform
2015-04-10 ダウングレード ROTH Capital Buy → Neutral
2015-02-26 繰り返されました ROTH Capital Buy
2015-02-18 繰り返されました Oppenheimer Outperform
すべてを表示

Ani Pharmaceuticals Inc (ANIP) 最新ニュース

pulisher
Aug 21, 2026

NFJ Investment Group LLC Takes $2.77 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 21, 2026
pulisher
Aug 21, 2026

Virtus Advisers LLC Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Quartz Partners LLC Makes New $1.61 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 20, 2026
pulisher
Aug 20, 2026

Great Lakes Advisors LLC Buys Shares of 61,481 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 20, 2026
pulisher
Aug 20, 2026

Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 20, 2026
pulisher
Aug 19, 2026

ANI (ANIP): Rises 1.37% to $77.92 for the Current Session; Boundary Watch: $74.02 and $81.82 Define the Nearby Reference Levels for the Current SessionHigh Dividend Factor - Vinanet

Aug 19, 2026
pulisher
Aug 19, 2026

ANI Pharmaceuticals (NASDAQ:ANIP): What Could Shift Sentiment? - Kalkine Media

Aug 19, 2026
pulisher
Aug 19, 2026

Rice Hall James & Associates LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript - AOL.com

Aug 18, 2026
pulisher
Aug 16, 2026

The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance

Aug 16, 2026
pulisher
Aug 15, 2026

ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold - Sahm

Aug 15, 2026
pulisher
Aug 15, 2026

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance

Aug 15, 2026
pulisher
Aug 15, 2026

Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? - TradingView

Aug 14, 2026
pulisher
Aug 14, 2026

ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth - Yahoo Finance

Aug 14, 2026
pulisher
Aug 13, 2026

ANI Pharmaceuticals (ANIP) Insider Sell: SR. VP, GENERAL COUNSEL & SEC. Meredith Cook Sells 500 Shares - GuruFocus

Aug 13, 2026
pulisher
Aug 13, 2026

ANI Pharmaceuticals Senior VP Meredith Cook Sells 500 Shares via 10b5-1 Trading Plan - Kalkine Media

Aug 13, 2026
pulisher
Aug 13, 2026

Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

ANI Pharmaceuticals (ANIP) counsel Meredith Cook sells 500 shares under 10b5-1 plan - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Amundi Has $352,000 Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Aug 13, 2026
pulisher
Aug 11, 2026

Ani Pharmaceuticals SVP Ori Gutwerg sells $243,474 in common stock. By Investing.com - Investing.com Australia

Aug 11, 2026
pulisher
Aug 11, 2026

Ori Gutwerg Sells 3,162 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Ani Pharmaceuticals SVP Ori Gutwerg sells $243,474 in common stock. - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

ANI Pharmaceuticals (ANIP) SVP, Generics Ori Gutwerg Sells 3,162 Shares - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

ANI Pharma SVP, Generics Ori Gutwerg reports sale of 3,162 common shares worth $243,474 - Bitget

Aug 11, 2026
pulisher
Aug 11, 2026

ANI Pharmaceuticals (ANIP) SVP Ori Gutwerg sells 3,162 shares at $77 - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration - Yahoo Finance

Aug 11, 2026
pulisher
Aug 10, 2026

Analysts cut ANI Pharmaceuticals targets despite Q2 earnings beat - scanx.trade

Aug 10, 2026
pulisher
Aug 10, 2026

Guggenheim cuts ANI Pharmaceuticals stock price target on Cortrophin guidance - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

Canaccord Genuity Group Cuts ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $90.00 - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Canaccord cuts ANI Pharmaceuticals stock price target on Cortrophin miss By Investing.com - Investing.com Canada

Aug 10, 2026
pulisher
Aug 09, 2026

ANI Pharmaceuticals (NASDAQ:ANIP): What Could Today Reveal? - Kalkine Media

Aug 09, 2026
pulisher
Aug 09, 2026

ANI Pharmaceuticals Inc (ANIP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026
pulisher
Aug 08, 2026

ANI Pharmaceuticals (ANIP) Could Be 31% Undervalued On Strong Q2 Results And Guidance Reset - finance.yahoo.com

Aug 08, 2026
pulisher
Aug 08, 2026

ANI Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ANIP) 2026-08-08 - Seeking Alpha

Aug 08, 2026
pulisher
Aug 08, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by Wall Street Zen - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Announces Earnings Results - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance - webull.com

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $109.12, Implies 32% Upside - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

Earnings call transcript: ANI Pharmaceuticals beats Q2 2026 estimates, shares fall premarket - Investing.com

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Q2 2026 slides: record results, gout expansion underway - Investing.com Nigeria

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Announces Q2 2026 Earnings and Releases Updated Investor Presentation - Kalkine Media

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals, Inc (ANIP) Q2 2026 Earnings Call Transcript - AlphaStreet

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Guidance Signals Fresh Momentum - Kalkine Media

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap DownHere's Why - marketbeat.com

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Q2 Earnings Call Highlights - marketbeat.com

Aug 07, 2026
pulisher
Aug 07, 2026

ANI Pharmaceuticals Shares Slide Despite Earnings Beat After Cortrophin Outlook Cut - Yahoo Finance

Aug 07, 2026

Ani Pharmaceuticals Inc (ANIP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$46.10
price down icon 1.66%
RDY RDY
$11.97
price down icon 0.50%
$24.50
price up icon 0.33%
$155.64
price down icon 1.71%
$16.88
price down icon 0.35%
$487.61
price down icon 0.54%
大文字化:     |  ボリューム (24 時間):